These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29454493)

  • 21. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Recommendations for Tardive Dyskinesia.
    Ricciardi L; Pringsheim T; Barnes TRE; Martino D; Gardner D; Remington G; Addington D; Morgante F; Poole N; Carson A; Edwards M
    Can J Psychiatry; 2019 Jun; 64(6):388-399. PubMed ID: 30791698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia: Out of the shadows.
    Hauser RA; Truong D
    J Neurol Sci; 2018 Jun; 389():1-3. PubMed ID: 29449008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive Dyskinesia.
    Tarsy D
    Curr Treat Options Neurol; 2000 May; 2(3):205-214. PubMed ID: 11096748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tardive dyskinesia].
    Zalyalova ZA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):25-31. PubMed ID: 37490662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Strategies for Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31880872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valbenazine for the treatment of tardive dyskinesia.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia.
    Aia PG; Revuelta GJ; Cloud LJ; Factor SA
    Curr Treat Options Neurol; 2011 Jun; 13(3):231-41. PubMed ID: 21365202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.
    Stegmayer K; Walther S; van Harten P
    CNS Drugs; 2018 Feb; 32(2):135-147. PubMed ID: 29427000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
    Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L
    CNS Spectr; 2022 Apr; 27(2):208-217. PubMed ID: 33213556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valbenazine for the treatment of tardive dyskinesia.
    Müller T
    Expert Rev Neurother; 2017 Dec; 17(12):1135-1144. PubMed ID: 28971695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VMAT2 inhibitors for the treatment of tardive dyskinesia.
    Scorr LM; Factor SA
    J Neurol Sci; 2018 Jun; 389():43-47. PubMed ID: 29433808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective.
    Citrome L
    Expert Rev Neurother; 2018 Apr; 18(4):323-332. PubMed ID: 29557243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review.
    Artukoglu BB; Li F; Szejko N; Bloch MH
    J Clin Psychiatry; 2020 May; 81(4):. PubMed ID: 32459404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive syndromes.
    Savitt D; Jankovic J
    J Neurol Sci; 2018 Jun; 389():35-42. PubMed ID: 29506749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive Dyskinesia: Treatment Update.
    Arya D; Khan T; Margolius AJ; Fernandez HH
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):69. PubMed ID: 31420757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].
    Sakata M; Ito H
    Brain Nerve; 2022 May; 74(5):571-574. PubMed ID: 35589649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroconvulsive Therapy as a Treatment for Tardive Dyskinesia.
    Yahya AS; Khawaja S
    Prim Care Companion CNS Disord; 2021 May; 23(3):. PubMed ID: 34000170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 29024264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.